Respiratory & Sleep Medicine\ COPD Flashcards

1
Q

What is COPD?

A

A chronic lung disease characterised by airflow limitation caused by airway (inflammation, increased mucous) and parenchymal destruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the strongest risk factor associated with the development of COPD?

A

Smoking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Does COPD worsen over time?

A

Yes, unlike asthma, COPD tends to be a progressive disease, especially if exposure to harmful substances usually smoking continues.

Reduction or elimination of exposures can significantly reduce the rate of lung function deterioration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the two types of COPD?

A

Chronic bronchitis and emphysema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is chronic bronchitis?

A
  • Chronic bronchitis is a chronic expiratory airflow obstruction with a cough, and excessive sputum production for at least three months in a year for two years.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is emphysema?

A
  • emphysema is chronic expiratory airflow obstructionwith enlargement of the airways, destruction of the alveoli and loss of elasticity of the alveolar walls.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Panacinar emphysema and lver cirrhosis developing in a young non-smoking patient is most likely due to what genetic disease?

A
  • alpha 1-antitrypsin deficiency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the common symptoms associated with COPD?

A
  • Cough
  • dyspnea
  • excessive sputum production
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Patient with COPD have what typical findings on chest X-ray?

A
  • ususally normal, but in advanced disease you may see flattened diaphragms, enlarged lung fields, increased AP diameter or interstitial markings with bullae.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

patients with COPD, have what typical findings in EKG?

A
  • usually normal but you may see
  • poor wave progression in this V1 to V6
  • right sided heart strain or
  • low voltage QRS due to increased chest diameter
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Do you have to document a flow obstruction on PFT is to make the diagnosis of COPD?

A

Yes, COPD is not a clinical diagnosis, but one that is made by spirometry.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

In COPD, is residual lung volume increased or decreased compared to patients without COPD?

A

increased.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

In most COPD patients, what do spirometric measurements (FEV1, FEV1/FVC) show pre and post bronchodilator therapy?

A
  • Reduced FEV1 pre-bronchodilator therapy indicates airway obstruction.
  • airway obstruction is largely irreversible.
  • Some COPD patients show mild post-bronchodilator FEV1 improvement, especially if their disease has a component of asthma.
  • However, the post bronchodilator FEV1/FVC ratio ratio always remained below 0.7 in COPD.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

The Global Initiative for Chronic Obstructive Pulmonary disease (GOLD) recommends taking diagnostic spirometric measurements after administration of a bronchodilator, to reduce testing variability.
According to GOLD what FEV1/FVC, and FEV1 values, are consistent with COPD?

A

According to GOLD in COPD, post bronchodilator FEV1/FVC is less than 0.7 and FEV1 one is less than 80% of predicted.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Mild (stage I) COPD

A
  • FEV1/FVC < 70%, FEV1 >/= 80% predicted
  • with or without symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Mild (stage I) COPD

  • treatment
A
  • FEV1/FVC < 70%, FEV1 >/= 80% predicted
  • with or without symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

moderate(stage II) COPD

A
  • FEV1/FVC < 70%
  • FEV1 = 50- 80% predicted
  • dyspnea with exertion
  • with or without cough and sputum production
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

moderate(stage II) COPD

  • treatment
A
  • FEV1/FVC < 70%
  • FEV1 = 50- 80% predicted
  • dyspnea with exertion
  • with or without cough and sputum production
  • Short acting bronchodilators + one or more LABA or anticholinergics + pulmonary rehabilitation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Severe (stage III) COPD

  • treatment
A
  • FEV1/FVC < 70%
  • FEV1 < 30% - 50%predicted
  • increased dyspnea
  • reduced exercise capacity
  • fatigue
  • repeated exacerbations
20
Q

Severe (stage III) COPD

  • treatment
A
  • FEV1/FVC < 70%
  • FEV1 < 30-50% predicted
  • increased dyspnea
  • reduced exercise capacity
  • fatigue
  • repeated exacerbations
21
Q

Severe (stage IV) COPD

  • treatment
A
  • FEV1/FVC < 70%
  • FEV1 < 30% predicted or
  • FEV1 < 50% plus respiratory failure
22
Q

Severe (stage IV) COPD

  • treatment
A
  • FEV1/FVC < 70%
  • FEV1 < 30% predicted or
  • FEV1 < 50% plus respiratory failure

Treatment = - Short acting bronchodilators + one or more LABA or anticholinergics + pulmonary rehabilitation + inhaled glucocorticoids for repeated exacerbation + oxygen therapy +/- surgery

23
Q

Inhaled corticosteroids are the mainstay of pharmacology COPD therapy and should be prescribed as first line treatment for most patients.

True or False?

A
  • False
  • bronchodilators are central to symptomatic, management of COPD.
24
Q

What are the different classes of bronchodilators use in the treatment of COPD?

A
  • Anticholinergics eg. Ipratropium
  • Short and long acting beta agonist
  • Methylxanthines eg theophylline.
25
Q

How do anticholinergics help keep airways open?

A
  • they inhibit muscarinic cholinergic receptors and reduce intrinsic vagal tone of airways
26
Q

Do steriods slow the FEV1 decline of COPD?

A
  • No
27
Q

What is the benefit of steroids in a COPD patient?

A
  • They decrease exacerbations, and are useful in an acute setting.
28
Q

What are the only interventions that have consistently shown effectiveness in decreasing mortality due to COPD?

A
  • smoking cessation decreases the progression of lung damage due to COPD, no matter how early or advanced the disease.
  • Oxygen prolongs life in patients with oxygen insufficiency.
29
Q

What interventions improve morbidity in COPD patients?

A
  • medications
  • smoking cessation
  • oxygen therapy
  • Influenza and pneumococcal vaccines
  • pulmonary rehabilitation.
30
Q

what are the components of pulmonary rehabilitation?

A
  • Exercise conditioning
  • breathing retraining
  • education
  • psychological support.
31
Q

In what ways does pulmonary rehabilitation, improve morbidity due to COPD?

A

It enhances quality of life

  • by reducing anxiety and depression symptoms
  • reducing heart hospitalization rates, and
  • improving exercise performance.

It does not improve overall pulmonary function.

32
Q

What are the indications for continuous long term oxygen therapy in patients with COPD?

A
33
Q

Acute exacerbations of COPD

  • common cause
A
  • infections
    • viruses
    • bacterial
      • Streptococcus pneumoniae
      • Moraxella catarrhalis
34
Q

Acute exacerbations of COPD

  • causes
A
  • infections
  • cardiac conditions
    • cardiac failure
    • arrythmias
  • chest trauma
  • Pulmonary conditions
    • pnemothorax
    • PE
  • Iatrogenic
    • inappropriate doses of Beta-blockers
    • narcotics
35
Q

What are the symptoms acute exacerbation of COPD?

A
  • worsening dyspnea
  • chest tightness
  • cough
  • wheezing
  • increased sputum production/tenacity
36
Q

What are the physical signs indicate a severe exacerbation?

A
  • use of accessory muscles.
  • Paradoxical chest movement
  • cyanosis,
  • signs of heart failure
    • edema
    • hemodynamic instability
  • mental status changes.
37
Q

What conditions can mimic the COPD exacerbation?

A
  • infection(pneumonia)
  • Pulmonary Embolism
  • pneumothorax,
  • pleural effusion
  • cardiac condition
    • arrhythmias
    • heart failure.
38
Q

What is the workup of COPD exacerbation?

A
  • arterial blood gases,
  • Chest X-ray
  • ECG
  • labs - CBC, BMP, BMP
  • spiral CT of pulmonary embolism is suspected.
39
Q

What is the treatment for acute exacerbation of COPD?

A
  • bronchodilator therapy
  • oxygen - with the aim of keeping saturation between 90 and 94%.
  • Oral IV corticosteroids
  • antibiotics for exacerbation caused by bacterial infection.
40
Q

Why should you monitor PCO2 while on oxygen therapy?

A

Oxygen can decrease the respiratory drive, causing the individuals PCO2.

41
Q

What is the treatment for hypercapnia?

A
  • BiPAP followed by intubation if needed.
42
Q

What does BiPAP stand for?

A
  • Bi-level (variable) positive airway pressure
43
Q

What does BiPAP do?

A
  • Mechanically delivers air through a mask at one pressure for inhaling (high) and at another for exhaling (low).
44
Q

In COPD patients what are the most common causes of pneumonia?
.

A
  • Viruses
  • H influenza
  • S pneumonia
  • M catarrhalis
45
Q

What is cor pulmonale?

A
  • cor pulmonale is a right sided heart failure resulting from long term increased pressure in the pulmonary vasculature and right ventricle.
  • It can be caused by a number of chronic pulmonary conditions including COPD.
46
Q
A